Can heart rate variability identify a high-risk state of upcoming seizure?


Journal

Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089

Informations de publication

Date de publication:
11 2023
Historique:
received: 23 05 2023
revised: 10 08 2023
accepted: 21 09 2023
medline: 3 11 2023
pubmed: 2 10 2023
entrez: 2 10 2023
Statut: ppublish

Résumé

Heart rate variability (HRV) is an accessible and convenient means to assess the sympathetic/parasympathetic balance. Autonomic dysfunctions may reflect a pro-ictal state and occur before the seizure onset. Previous studies have reported HRV-based models to identify preictal states in continuous electrocardiogram (EKG) monitoring. Here, we evaluated the ability of HRV metrics extracted from daily single resting-state periods to estimate the risk of upcoming seizure(s) using probabilistic forecasts. Daily standardized 10-min vigilance-controlled EKG periods were recorded in 15 patients with drug-resistant focal epilepsy who underwent intracerebral electroencephalography (EEG). Analyses of a total of 156 periods, based on machine learning approaches, suggested that HRV features can identify preictal states with a median AUC of 0.75 [0.68;0.99]. Pseudoprospective daily forecasts yielded a median Brier score of 0.3 [0.18;0.48]. About 60% of preictal days were correctly forecasted, while false positive predictions were noticed in 24% of interictal days. Daily resting HRV seems to capture information on autonomic variations that may reflect a pro-ictal state. The method could be embedded in an ambulatory clinical seizure prediction device, but additional modalities (prodromes, EEG-based features, etc.) should be associated to improve its performance.

Identifiants

pubmed: 37783038
pii: S0920-1211(23)00157-2
doi: 10.1016/j.eplepsyres.2023.107232
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107232

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure of conflicts of interest V.N. reports fees from Boards with UCB Pharma, EISAI, GW Pharma. The remaining authors have no conflicts of interest.

Auteurs

Louis Cousyn (L)

Paris Brain Institute (Inserm, CNRS, Sorbonne Université), Paris, France; AP-HP, Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital, Paris, France. Electronic address: louismarc.cousyn@aphp.fr.

Fedele Dono (F)

Department of Neuroscience, Imaging and Clinical Sciences, "G. d'Annunzio" University of Chieti -Pescara, Chieti, Italy.

Vincent Navarro (V)

Paris Brain Institute (Inserm, CNRS, Sorbonne Université), Paris, France; AP-HP, Department of Neurology, Epilepsy Unit, Pitié-Salpêtrière Hospital, Paris, France.

Mario Chavez (M)

CNRS UMR-7225, Pitié-Salpêtrière Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH